Group One Trading
FBIO icon

Group One Trading’s Fortress Biotech FBIO Stock Holding History

Group One Trading’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$497K Buy
178,000
+10,800
+6% +$36.7K ﹤0.01% 3354
2025
Q4 		$612K Sell
167,200
-112,800
-40% -$321K ﹤0.01% 3307
2025
Q3 		$1.03M Buy
280,000
+229,500
+454% +$580K ﹤0.01% 2999
2025
Q2 		$93.9K Buy
50,500
+39,100
+343% +$67.7K ﹤0.01% 5022
2025
Q1 		$17.8K Buy
11,400
+6,900
+153% +$12.2K ﹤0.01% 5899
2024
Q4 		$9.11K Buy
4,500
+3,600
+400% +$6.52K ﹤0.01% 6146
2024
Q3 		$1.3K Buy
900
+500
+125% +$952 ﹤0.01% 6246
2024
Q2 		$684 Hold
400
– – ﹤0.01% 6420
2024
Q1 		$800 Buy
+400
New +$796 ﹤0.01% 6680
2021
Q3 		– Sell
-467
Closed -$25K – 8337
2021
Q2 		$25K Buy
+467
New +$28.2K ﹤0.01% 7051
2018
Q3 		– Sell
-1,013
Closed -$45K – 5308
2018
Q2 		$45K Hold
1,013
– – ﹤0.01% 4005
2018
Q1 		$69K Buy
1,013
+720
+246% +$45.6K ﹤0.01% 3483
2017
Q4 		$18K Sell
293
-207
-41% -$12.2K ﹤0.01% 4182
2017
Q3 		$33K Sell
500
-807
-62% -$54.4K ﹤0.01% 3834
2017
Q2 		$93K Buy
1,307
+1,287
+6,435% +$76K ﹤0.01% 3159
2017
Q1 		$1K Buy
+20
New +$895 ﹤0.01% 4496
2016
Q4 		– Sell
-1,333
Closed -$59K – 4522
2016
Q3 		$59K Buy
+1,333
New +$56.7K ﹤0.01% 3256
2015
Q2 		– Sell
-227
Closed -$13K – 4931
2015
Q1 		$13K Sell
227
-1,353
-86% -$56.4K ﹤0.01% 4057
2014
Q4 		$58K Buy
1,580
+827
+110% +$24.4K ﹤0.01% 3269
2014
Q3 		$24K Sell
753
-10,967
-94% -$291K ﹤0.01% 4011
2014
Q2 		$302K Sell
11,720
-5,913
-34% -$156K ﹤0.01% 2047
2014
Q1 		$524K Buy
17,633
+10,466
+146% +$408K 0.01% 1603
2013
Q4 		$283K Buy
7,167
+334
+5% +$12.9K ﹤0.01% 2130
2013
Q3 		$720K Buy
6,833
+6,313
+1,214% +$774K 0.01% 1283
2013
Q2 		$67K Buy
+520
New +$76.7K ﹤0.01% 3166

Other funds holding FBIO

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Group One Trading's FBIO Position: Q1 2026 in Review

Group One Trading sold out of Fortress Biotech (FBIO) in Q1 2026, closing a stake of 63,692 shares — an estimated $216K sold.

Group One Trading first reported a position in FBIO in Q2 2013 and held it in 25 quarters. The position peaked at $311K in Q2 2013. 51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

  • Group One Trading reported no remaining Fortress Biotech position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 63,692 Fortress Biotech shares in Q1 2026, an estimated $216K.
  • Group One Trading first reported a position in Fortress Biotech in Q2 2013 and held it in 25 quarters.
  • Group One Trading's Fortress Biotech position peaked at $311K in Q2 2013.
  • 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.